期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌新辅助内分泌治疗进展

下载PDF
导出
摘要 1概述 自1896年Beatson首次揭示了乳腺癌与卵巢内分泌功能之间的密切关系[1],到抗雌激素药物他莫苷芬（TAM）的临床广泛应用已有百年历史,内分泌治疗乳腺癌的价值已越来越被人们所认识和接受。
作者 贾浩欣 王闽全
机构地区 新疆医科大学第二附属医院肿瘤外科
出处 《中国医院用药评价与分析》 2010年第8期766-768,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 新辅助内分泌治疗 乳腺癌 卵巢内分泌功能 抗雌激素药物
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献26

  • 1Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrativecases [ J ]. Lancet, 1896,2 : 104.
  • 2Jordan VC. Tamoxifen: a most unlikely pioneering medicine [ J ]. Nat Rev Drug Discov,2003,2 ( 3 ) :205.
  • 3Gradishar W J. Recently initiated studies: neoadjuvant treatments in next century [J]. Semi Oncol, 1999,26( 1 suppl 3 ) :26.
  • 4Miller WR, Dixon JM. Local endocrine effects of aromatase inhibitors within the berast [ J ]. J Steroid Biochem Mol Biol, 2001,79 ( 1 - 5 ) :93.
  • 5Tan SM, Cheung KL, Willsher PC, et al. Locally advanced primary breast cancer: medium - term results of arandomized trial of multimodal therapy versus initial hormone therapy[ J]. Eur J Cancer,2001,37 ( 18 ) :2331.
  • 6张斌.乳腺癌新辅助内分泌治疗[J].中国癌症杂志,2006,16(9):689-692. 被引量：9
  • 7Manriac L, Debled M, Durand M, et al. Neoadjuvant tamoxifen for hormone - sensitive non - metastatic breast carcinoma in early postmenopausal women [ J ]. Ann Oncel,2002,13 ( 2 ) :293.
  • 8Dixon JM, Anderson TJ, Miller WR. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective [J]. Eur J Cancer,2002,38(17):2214.
  • 9Eiemann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole:A randomized double - blind multicenter study [ J].Ann Oncol,2001,12(11) :1527.
  • 10李荣萍,任佳,吕文静,张立娜,刘峰.来曲唑在绝经后乳腺癌新辅助内分泌治疗中的应用[J].山东医药,2009,49(32):67-69. 被引量：8

二级参考文献39

  • 1王晓红,章爱斌,倪俊,顾凤元.来曲唑在绝经后乳腺癌患者新辅助化疗中的应用价值探讨[J].浙江医学,2006,28(6):502-503. 被引量：9
  • 2Mouridsen H, Gershanovich M, Sun Y, et al. Superior efficacy ofletrozole versus tamoxifen as first-line therapy for postmenopausal- women with advanced breast cancer: results of a phase Ⅲ study of- the international letrozole breast cancer group [ J ]. Clin Oncol, 2001,19(10) :2596-2606.
  • 3Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: aran- domized double-blind muhicenter study [J]. Ann Oncol, 2001,12 ( 11 ) :1527-1532.
  • 4Lipton A, Ali SM, Leitzel K, et al. Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen [ J ]. J Clin Oncol, 2003,21 ( 10 ) : 1967-1972.
  • 5Bolufer P, Ricart E, Lluch A, et al. Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging. J Clin Oncol, 1992,10(3) :438-446.
  • 6Mauriac L, Debled M, Durand M, et al. Neoadjuvant tamoxifen for hormone- sensitive non-metastatic breast carcinomas in early postmenopausal women. Ann Oncol,2002,13 (2) :293-298.
  • 7Dixon JM,Anderson TJ, Miller WR. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective. Eur J Cancer, 2002,38 ( 17 ) :2214-2221.
  • 8Eiemann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol, 2001, 12 ( 11 ) : 1527- 1532.
  • 9Olson JA Jr, Budd GT, Carey LA, et al. Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy:results from a multicenter phase Ⅱ trial. J Am Coll Surg,2009, 208(5) :906-914.
  • 10Smith IE, Dowsett M, Ebbs SR, et al. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination : the immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen(IMPACT) muhicenter double-blind randomized trial. J Clin Oncol, 2005, 23(22) :5108-5116.

共引文献63

中国医院用药评价与分析
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部